Berlin, Germany

Karl Skriner

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.3

ph-index = 1


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Karl Skriner

Introduction

Karl Skriner is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of anti-tumor treatments. With a total of six patents to his name, Skriner's work has the potential to impact patient care and treatment outcomes.

Latest Patents

One of his latest patents focuses on a biomarker for predicting responsiveness to anti-tumor necrosis factor alpha (TNF) treatment. This invention outlines a method for diagnosing individuals who are undergoing or are to undergo anti-TNF treatment. The method involves detecting immunoglobulins against specific biomarker proteins in bodily fluids or excrement. Based on this detection, individuals can be classified as either responders or non-responders to the treatment. Additionally, the patent includes diagnostic kits that utilize these biomarker proteins to assess treatment responsiveness.

Career Highlights

Throughout his career, Karl Skriner has worked with prestigious organizations such as the Max Planck Society for the Advancement of Science and Charité – Universitätsmedizin Berlin. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Zoltán Konthur and Hans Lehrach. Their collaborative efforts have further advanced the research and development of innovative diagnostic methods.

Conclusion

Karl Skriner's contributions to medical diagnostics through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for improved treatment strategies for patients undergoing anti-TNF therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…